HANOVER INSURANCE GROUP, INC. Earnings Per Share Disclosure
10. EARNINGS PER SHARE AND SHAREHOLDERS’ EQUITY TRANSACTIONS
The following table provides weighted average share information used in the calculation of the Company’s basic and diluted earnings per share:
DECEMBER 31 |
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
(in millions, except per share data) |
|
|
|
|
|
|
|
|
|
|||
Basic shares used in the calculation of earnings per share |
|
|
35.8 |
|
|
|
35.9 |
|
|
|
35.7 |
|
Dilutive effect of securities: |
|
|
|
|
|
|
|
|
|
|||
Employee stock options |
|
|
0.3 |
|
|
|
0.2 |
|
|
|
0.1 |
|
Non-vested stock grants |
|
|
0.4 |
|
|
|
0.3 |
|
|
|
0.3 |
|
Diluted shares used in the calculation of earnings per share |
|
|
36.5 |
|
|
|
36.4 |
|
|
|
36.1 |
|
Per share effect of dilutive securities on income from |
|
$ |
(0.34 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.01 |
) |
Diluted earnings per share during 2025, 2024 and 2023 excludes 0.1 million, 0.4 million and 0.3 million, respectively, shares of common stock issuable under the Company’s stock compensation plans, because their effect would be antidilutive.
The Board of Directors authorized a stock repurchase program which provides for aggregate repurchases of the Company’s common stock of up to $1.3 billion. Under the repurchase authorization, the Company may repurchase, from time to time, common stock in amounts, at prices and at such times as the Company deems appropriate, subject to market conditions and other considerations. Repurchases may be executed using open market purchases, privately negotiated transactions, accelerated repurchase programs or other transactions. The Company is not required to purchase any specific number of shares or to make purchases by any certain date under this program. During 2025, the Company repurchased approximately 0.7 million shares through open market purchases at an aggregate cost of $130.1 million. Included in the cost of treasury stock acquired pursuant to common share repurchases in 2025 is the 1% excise tax imposed on common share repurchase activity, net of common share issuances, as part of the Inflation Reduction Act of 2022. During 2024, the Company repurchased approximately 0.2 million shares through open market repurchases at an aggregate cost of $26.7 million. The Company did not repurchase any shares during 2023. As of December 31, 2025, the Company had repurchased 8.8 million shares under this $1.3 billion program and had approximately $173 million available for additional repurchases.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 20, 2026 | Showing above |
| 2024 | Feb 24, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 23, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 24, 2021 | |
| 2019 | Feb 24, 2020 | |
| 2018 | Feb 22, 2019 | |
| 2017 | Feb 27, 2018 | |
| 2016 | Feb 22, 2017 | |
| 2015 | Feb 25, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.